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Phosphatidylinositol 3-kinase (PI3K) has numerous
cellular functions, including cell survival and prolifera-
tion. In this study, we demonstrated that the expression
of the active form of PI3K induced dorsal differentiation
and axis duplication and strongly induced the expres-
sion of neural markers. In contrast, the inhibition of
PI3K activity by its dominant negative mutant induced
the phenotype of losing posterior structures and the
expression of ventral markers. Akt is an essential target
of PI3K for neurogenesis. The expression of the active
form of Akt induced axis duplication and increased the
expression of neural markers. Inhibition of the Akt ac-
tivity abolished the PI3K-induced double heads and
axes. This signal transmits through its target, glycogen
synthase kinase 3, which is known to mediate Wnt
signaling for Xenopus development. These results iden-
tify a new function of PI3K/Akt signaling in axis forma-
tion and neurogenesis during Xenopus embryonic devel-
opment and provide a direct link between growth
factor-mediated PI3K/Akt signaling and Wnt signaling
during embryonic development.
Phosphatidylinositol 3-kinase (PI3K)1 is a heterodimeric
enzyme composed of a 110-kDa catalytic and an 85-kDa regu-
latory subunit (1). PI3K phosphorylates the D3 hydroxyl of
phosphoinositides and produces phosphatidyl-inositol-3-phos-
phates. PI3K is activated by several receptor and nonreceptor
protein tyrosine kinases (2, 3). The best known downstream
target of PI3K is the serine-threonine kinase Akt, which trans-
mits survival signals from growth factors (4, 5). Activation of
Akt requires the following two factors: (i) the binding of the
lipid second messengers to its intact pleckstrin homology do-
main; and (ii) the phosphorylation of the pleckstrin homology
domain by the phosphoinositide-dependent kinase (6, 7). Akt
has multiple downstream targets, including nitric oxide syn-
thase (8–10), NF-B (11–13), BAD (14), and glycogen synthase
kinase 3 (15). PI3K and Akt are involved in multiple cellular
functions such as cell survival, proliferation, transformation,
myogenic differentiation, angiogenesis, and cytoskeletal
changes (6, 7, 16–22). However, the roles of PI3K and Akt in
embryonic development still remain to be elucidated. We hy-
pothesize that PI3K signaling plays an important role in em-
bryonic development because PI3K is commonly activated by
growth factors, some of which display dorsalizing activity to
induce a secondary axis in Xenopus embryos. Here we used
Xenopus as a model system to investigate the roles of PI3K and
Akt in embryonic development. To determine whether PI3K is
sufficient to induce a dorsal phenotype, an active form of PI3K
was expressed in Xenopus embryos, and its effect on develop-
ment was studied; to determine whether PI3K activity is re-
quired, a dominant negative form of PI3K was expressed to
specifically inhibit endogenous PI3K activity in the embryos.
To further understand the downstream signaling molecules
involved in PI3K-mediated embryo development, we analyzed
the effects of Akt and identified Akt as an essential target
through the forced activation or inhibition of its activity in the
embryos. We also used a similar approach to identify GSK-3
as a potential target of Akt to mediate the PI3K-initiated
developmental cue in Xenopus embryos.
EXPERIMENTAL PROCEDURES
Embryo Manipulation—Adult pigmented Xenopus laevis specimens
were obtained from Xenopus I, Inc. (Dexter, MI). Xenopus laevis em-
bryos were obtained by artificial insemination after females were in-
jected with 500 units of human chorionic gonadotropin. The embryos
were chemically dejellied using 2% cysteine and then washed and
transferred to Petri dishes containing 0.3 MMR solution (0.1 M NaCl,
2 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 5 mM HEPES, and 0.1 mM EDTA)
and 3% Ficoll (Amersham Biosciences). The embryos were staged ac-
cording to Nieuwkoop and Faber’s table (23).
Plasmid Construction and RNA Preparation—cDNA clones encoding
-galactosidase (-gal) have been described previously (24). The cDNA
constructs encoding an active form of the PI3K catalytic subunit,
p110*, and a dominant negative form of the PI3K regulatory subunit,
p85iSH2, were inserted into pSG5 vector and linearized by SalI for in
vitro synthesis of capped sense mRNA using the T7 transcription kit
(Ambion, Austin, TX). Myr-Akt, an active form of Akt, was inserted into
pBluescript II KS, and linearized by NotI for in vitro synthesis of
capped sense mRNA using the T7 transcription kit. DN-Akt constructed
in PBS-Sfi vector was linearized by SalI for in vitro synthesis of capped
sense mRNA using the T3 transcription kit (Ambion). Cellular GSK-3
and a dominant negative mutant of GSK-3, DN-GSK-3, were sub-
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cloned into pSP64TEN vector and linearized by XbaI for in vitro syn-
thesis of capped sense mRNA using the Sp6 transcription kit (Ambion),
according to the manufacturer’s instruction. The synthetic RNAs were
quantitated by ethidium bromide staining with reference to standard
RNA (24).
Embryo Injection and Explant Culture—Embryos at the two-cell
stage were injected in the animal poles with various mRNAs. The
embryos were cultured up to 45 stages after injection. Animal caps were
dissected from the injected embryos at stages 8.5–9 and cultured at
22 °C in 67% Leibovitz’s L-15 medium (Invitrogen) with 7 mM Tris-HCI
(pH7.5) and gentamicin (50 g/ml) to various stages before being har-
vested for RT-PCR for further analysis.
RT-PCR—Total RNAs were extracted from cultured animal cap ex-
plants with TRIzol reagent (Invitrogen) in accordance with the manu-
facturer’s instructions. RT-PCR amplification was performed using a
Superscript preamplification system (Invitrogen). The primer sets and
PCR condition for EF-1, NCAM, BMP-4, Xvent-1, Xmsx1, Otx2, and
Hoxb9 were as described previously (24–26). The primers designed for
Xvent-2 5-GGA CTA TAC TAA AGG CTG GA-3 (forward) and 5-ATT
ACT CAT AGA ATA TAC AC-3 (reverse). PCR conditions for Xvent-2
were 95 °C for 5 min followed by 32 cycles of 94 °C for 1 min, 60 °C for
45 s, and 72 °C for 1 min. PCR products were analyzed by data from
replicate experiments.
RESULTS
Ectopic Expression of PI3K Induces Double Heads and Dor-
sal Axes—The PI3K pathway has been demonstrated to play a
significant role in cell survival, proliferation, protein synthesis,
myogenic differentiation, and angiogenesis. However, the role
of PI3K in development still remains to be defined. To under-
stand the role of PI3K signaling during early Xenopus devel-
opment, we overexpressed an active form of the PI3K catalytic
subunit, p110* (27, 28). The expression of p110* increased
PI3K activity in the embryos dose-dependently (Fig. 1A). The
embryos expressing p110* developed with double heads and
dorsal axes (Fig. 1B). This result indicated that the activation
of PI3K is sufficient to induce axis duplication and is a potent
inducer for neurogenesis during Xenopus embryonic develop-
ment. To test whether PI3K is required for embryo develop-
ment, a truncated form of the p85 regulatory subunit of PI3K,
p85iSH2, was expressed. p85iSH2 is unable to bind to the
catalytic subunit of PI3K but retained its ability to bind to the
receptor tyrosine kinases, thereby specifically inhibiting endog-
enous PI3K activation by growth factors (12, 21). Ectopic ex-
pression of p85iSH2 during Xenopus embryonic development
produced a losing posterior structure phenotype at the tadpole
stage, which lacked apparent axial structures and had a short
tail and well patterned ventral tissues (Fig. 1C). These data
suggested that PI3K activation is required for dorsal axis de-
velopment in Xenopus embryos. To investigate whether ectopic
expression of the active form of PI3K, p110*, may reverse the
inhibitory effect of p85iSH2 on the activation of PI3K by
receptor tyrosine kinases, both p110* and p85iSH2 were
co-expressed in the Xenopus embryos. The expression of p110*
bypassed the p85iSH2 inhibitory effect and restored Xenopus
phenotypes similar to those of the control (Fig. 1D). Taken
together, these results suggested that PI3K activity is essential
for axis duplication in Xenopus development.
PI3K Signaling Is Required for Neural Tissue Induction in
Animal Caps—The blastula animal cap is composed of pluri-
potent cells that can be induced to form endodermal, mesoder-
mal, or ectodermal cell types and is a useful tissue for assessing
the roles of various inducing factors in development. To study
further the role of PI3K activity in neurogenesis, Xenopus
embryos at the two-cell stage were injected with mRNAs coding
for -gal as a control or p110*. Animal caps were dissected at
stages 8.5–9 and cultured in 67% Leibovitz’s L-15 medium until
the equivalent of stage 22. Expression of p110* induced a
neural like extension (Fig. 2A). Co-expression of p85iSH2
inhibited p110*-induced neural development, and the pheno-
type was similar to that of the control and the caps treated with
p85iSH2 alone. RT-PCR analysis demonstrated that p110*
induced pan-neural marker NCAM expression, whereas
p85iSH2 inhibited the p110*-induced NCAM expression.
Expression of the mesoderm tissue marker Xbra was negative,
which implied no mesoderm tissue induction (Fig. 2B). This
result suggests that activation of PI3K is sufficient to mediate
neural development in Xenopus embryos. To study the role of
PI3K activity in neural development mediated by other up-
stream inducers, we tested whether the inhibition of endoge-
nous PI3K activity by LY294002 or p85iSH2 affected neural
development in animal caps induced by retinoic acid. Retinoic
acid is a derivative of vitamin A and a potent teratogen. In
vertebrates, retinoic acid is involved in the development of the
central nervous system and is a neural inducing factor (25).
Xenopus embryos at the two-cell stage were injected with
mRNAs coding for -gal control or p85iSH2. Animal caps
were dissected at stages 8.5–9 and cultured in 67% Leibovitz’s
L-15 medium with retinoic acid in the absence or presence of
LY294002 until the equivalent of stage 22. Animal caps in-
duced by retinoic acid and injected with -gal developed a
neural like phenotype. Their appearance was slightly swollen
and elongated, with one side white and the other side black. In
contrast, animal caps injected with p85iSH2 or treated with
LY294002 developed an epidermal like phenotype. They had a
FIG. 1. Activation or inhibition of PI3K by expression of an
active form of PI3K, p110*, or a dominant negative form of
PI3K, p85iSH2, affects Xenopus embryo development. The em-
bryos at the two-cell stage were injected into the animal pole area with
1 ng of mRNA encoding -gal (a negative control), p110*, or p85iSH2.
The embryos were cultured in 30% MMR solution until the equivalent
of stage 45 after the injection. A, cellular extracts were prepared from
the embryos and used for a PI3K activity assay in vitro, as we described
previously (19). Left lane, vector control; middle and right lanes, injec-
tion of 0.5 and 1 g of p110*, respectively. B, compared with the -gal
control, the embryos injected with p110* produce a dorsalizing phe-
notype (double heads and axes 36/50, 72%). C, the embryos injected
with a dominant negative construct of PI3K, p85iSH2, produce a
ventralizing phenotype with a short tail and a small head (34/50, 68%).
D, the co-expression of p110* and p85iSH2 in the embryos results in
a normal phenotype similar to the control (double heads and axes
4/50, 8%).
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round shape and were evenly brownish in color (Fig. 2C).
LY294002 and p85iSH2 inhibited retinoic acid-induced
NCAM expression. Mesoderm induction was also excluded as a
negative Xbra expression (Fig. 2D). These data further suggest
that PI3K is required for neural development of the Xenopus
embryo.
Akt Is a Sufficient Downstream Target of PI3K for Axis
Duplication—The serine-threonine kinase Akt is a well known
target of PI3K, which mediates PI3K-induced multiple func-
tions in response to growth factors in vitro. To test whether Akt
activity is regulated by PI3K in the embryos, relative Akt
activity in response to the activation of PI3K activity was
determined in these cells. The expression of p110* induced
the phosphorylation of Akt at Ser-473, which determines Akt
activation in the cells (Fig. 3A). To test whether Akt is suffi-
cient to mediate the process, an active form of Akt, Myr-Akt,
was expressed in the embryos by microinjection of its mRNA.
When compared with the -gal control, ectopic expression of
Myr-Akt also induced axis duplication (Fig. 3B). This pheno-
type was similar to that observed in the embryos by the expres-
sion of PI3K, indicating that Akt is a target of PI3K for the
process. To further determine whether Akt activity is required,
endogenous Akt activity was inhibited by the expression of a
dominant negative mutant of Akt, DN-Akt. The expression of
DN-Akt inhibited axis formation, resulting in a phenotype with
a shorter tail and smaller head than those of the -gal control
(Fig. 3C). These data suggest that Akt is required for axis
induction during embryo development. To determine whether
Akt activity is required for PI3K-induced axis duplication, DN-
Akt was co-expressed with the active form of PI3K, p110*.
The co-expression of DN-Akt inhibited PI3K-induced axis du-
plication, resulting in a normal phenotype similar to that of the
control (Fig. 3D). Similarly, the expression of DN-Akt also
inhibited Myr-Akt-induced axis duplication in embryo develop-
ment (Fig. 3E). These data further confirmed that Akt is an
essential downstream target of PI3K for axis formation and
neurogenesis during Xenopus embryonic development.
PI3K and Akt Induced Axis Formation through the Inhibition
of GSK-3 during Xenopus Development—The activation of Akt
is known to induce the phosphorylation and inactivation of
GSK-3 in the cells. To determine whether GSK-3 is a func-
tional downstream target of Akt for inducing dorsal axis for-
mation, cellular GSK-3 was co-expressed with active forms of
PI3K or Akt in the embryos. Co-injection of cellular GSK-3
reversed the effects by the expression of PI3K and Akt on axis
induction and resulted in a normal phenotype similar to that of
the control (Fig. 4). This result suggests that PI3K and Akt
induced axis formation through the inhibition of GSK-3.
PI3K and Akt Signaling Is Required for the Expression of
Neural and Ventral Markers during Embryo Development—To
study the roles of PI3K and Akt signaling in neural develop-
ment in Xenopus embryos, the expression of neural and ventral
markers was analyzed by performing RT-PCR using RNA ex-
tracted from the initial neural stage of embryos. Xenopus em-
bryos at the two-cell stage were injected with mRNAs encoding,
respectively, -gal, p110*, p85iSH2, Myr-Akt, DN-Akt,
GSK-3, or DN-GSK-3. Animal caps were dissected at stages
8.5–9 and cultured until the equivalent of stage 13 for the
analysis of neural and ventral markers. p110*, Myr-Akt, and
DN-GSK-3 induced the expression of the pan-neural marker
NCAM (29), the anterior neural marker Otx2 (30, 31), and the
posterior neural marker HoxB9 (32), whereas p85iSH2, DN-
Akt, and GSK-3 induced the expression of the ventral mark-
ers Xvent1, Xvent2, BMP-4, and Xmsx1 (Fig. 5A). EF-1
mRNA expression was used as an internal control to indicate
that similar RNA amounts and reaction conditions were used.
This result further confirmed that PI3K and Akt were involved
in the neurogenesis of Xenopus embryonic development.
To further elucidate the signaling pathway leading to the
expression of neural markers and neural development, we ex-
plored whether the inhibition of PI3K and Akt activity or the
ectopic expression of GSK-3 could inhibit the induction of
neural marker expression. The expression of the PI3K domi-
nant negative mutant p85iSH2 inhibited PI3K-induced, but
not Akt- and DN-GSK-3-induced, neural marker expression
(Fig. 5B). This result is consistent with a position for PI3K
upstream of Akt and GSK-3 for mediating neural marker
FIG. 2. PI3K activity mediates neural tissue induction. A, em-
bryos at the two-cell stage were injected with mRNA coding for -gal
(control), p110*, p110* plus p85iSH2, or p85iSH2 as indicated.
The animal caps were dissected at stages 8.5–9 and then cultured in
67% Leibovitz’s L-15 medium until the equivalent of stage 22 for pho-
tography. The ectopic expression of p110* induced neural tissue,
which was inhibited by the co-expression of p85iSH2. B, animal caps
were harvested at the equivalent of stage 22 for RT-PCR and analysis
of the expression of the pan-neural marker NCAM and the mesoderm
marker Xbra. EF-1 expression was used as an internal control. C,
retinoic acid (RA)-induced neural tissue development was inhibited by
LY294002 and p85iSH2. The embryos at the two-cell stage were
injected with -gal (control) or p85iSH2 into the animal pole area. The
animal caps were dissected at stages 8.5–9 and incubated in 67%
Leibovitz’s L-15 medium with retinoic acid (105m) in the absence or
presence of 50 M LY294002 until the equivalent of stage 22 for pho-
tography. D, animal caps were also harvested at the equivalent of stage
22 for analysis of the expression of NCAM and Xbra by RT-PCR. No RT,
absence of reverse transcriptase.
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expression and axis induction. The expression of Akt dominant
negative mutant DN-Akt inhibited both PI3K- and Akt-induced
neural marker expression but not DN-GSK-3-induced neural
marker expression. However, the expression of the ventral
markers (i.e. Xvent1, Xvent2, BMP4, and Xmsx1) induced by
p85iSH2, DN-Akt, and GSK-3 were blocked by p110*, Myr-
Akt, and DN-GSK-3, respectively. These data further con-
firmed that Akt mediated neural marker expression and axis
formation through the inhibition of GSK-3.
In conclusion, this study has demonstrated a novel role of
PI3K in mediating axis formation and neural development in
Xenopus embryos. The activation of PI3K is transmitted
through its downstream target, Akt, which inhibits the activa-
tion of GSK-3 for the process (Fig. 5C).
DISCUSSION
PI3K and the Akt signaling pathway play an important role
in many cellular functions, including survival, proliferation,
protein synthesis, and differentiation. In this study, we dem-
onstrated that ectopic expression of an active form of PI3K was
sufficient to induce axis duplication and neurogenesis through
the increased expression of neural markers such as NCAM,
Otx2, and HoxB9 and that the inhibition of PI3K activity by a
PI3K inhibitor or a PI3K dominant negative mutant inhibited
axis formation and neural development. PI3K was also found to
transmit retinoic acid-induced mesoderm induction and a neu-
ral like phenotype (Fig. 2). This result is consistent with recent
observations that PI3K, Ras, and mitogen-activated protein
kinase/extracellular signal-regulated protein kinase kinase
(MEK) have a synergistic effect in mesoderm induction by the
fibroblast growth factor signaling pathway (33). This study also
showed that overexpression of an active form of Akt induced
double heads and axes and the expression of neural markers
such as NACM, Otx2, and Hoxb9 (Figs. 3 and 5). The inhibition
of Akt activity by DN-Akt induced Xenopus to produce a ventral
FIG. 3. Akt is an essential downstream target of PI3K in mediating axis duplication. A, the activation of Akt by p110*. Protein extracts
were prepared from the embryos as described in Fig. 1 and used for an immunoblot assay using specific antibodies against phospho-Akt at Ser-473
(19, 20). B, ectopic expression of an active form of Akt, Myr-Akt, induces dorsal axis duplication. The embryos at the two-cell stage were injected
in the animal pole area with 1 ng of mRNA encoding Myr-Akt or -gal (control). The embryos were cultured in 30% MMR solution until the
equivalent of stage 45 after the injection. Embryos injected with Myr-Akt generated a dorsalizing phenotype with double heads and axes (35/50,
70%). C, the embryos injected with a dominant negative construct of Akt, DN-Akt, produced a ventralizing phenotype with a short tail and a small
head (31/50, 62%). D, Akt is required for PI3K-induced axis induction. The embryos were injected with mRNAs for -gal (control), p110*, or
p110* and DN-Akt and cultured in 30% MMR solution until the equivalent of stage 45. The phenotypes were observed and photographed at stage
45. E, the embryos were injected with mRNAs for -gal (control), Myr-Akt, or Myr-Akt and DN-Akt and cultured as above. Expression of DN-Akt
inhibited p110*- and Myr-Akt-induced axis duplication and restored to embryos phenotypes similar to those of the control.
FIG. 4. GSK-3 is a downstream negative regulator in PI3K- and Akt-induced axis duplication. A, embryos were injected with mRNA
coding for -gal (control), p110*, or p110* and GSK-3 and cultured in 30% MMR solution until the equivalent of stage 45 as above. B, embryos
were injected with mRNA coding for -gal (control), Myr-Akt, or Myr-Akt and GSK-3 and cultured in 30% MMR solution until stage 45. Axis
duplication was observed by the expression of p110* and Myr-Akt, and the co-expression of GSK-3 completely inhibited PI3K- and Akt-mediated
axis induction, resulting in normal phenotypes.
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phenotype and expression of the ventral markers, including
Xvent1, Xvent2, BMP-4, and Xmsx1. These data indicated that
Akt is an essential downstream target of PI3K for mediating
axis formation and neural development. Our results provide
the first evidence that PI3K and Akt are involved in axis
formation and neurogenesis in vertebrate embryonic develop-
ment. Dorsoventral patterning in Xenopus embryos requires
multiple inductive events involving Niewkoop center action,
mesoderm induction, and formation of the Spemann organizer
(34–36). The effects of PI3K and Akt on Xenopus embryogene-
sis are similar to those of noggin (37), goosecoid (38), chordin
(39), follistatin (40), siamois (41), Xwnt-1 (42), and Xwnt-8 (37,
44), which can function as dorsalizing signals. Unlike Xwnt8,
noggin, and chordin, however, PI3K activity is restricted to the
equatorial region of the embryo during normal embryogenesis
and is required for trunk mesoderm induction (34).
Akt is required for PI3K-mediated cell growth and survival.
Overexpression of constitutively active forms of PI3K or Akt
induces oncogenic transformation in culture cells and tumors
in animals (18, 45). We have previously reported that PI3K
activity is required for myogenic differentiation (19). Akt is an
essential downstream target for mediating PI3K-induced myo-
genesis (20). Similarly, Akt also stimulates the differentiation
of adipocytes. PI3K and Akt also share a common effect in
mediating angiogenesis, as we have observed previously (21).
The effects of PI3K and Akt signaling on axis formation and
neurogenesis are very similar to the effects reported for skele-
tal myogenesis and angiogenesis (19–21).
GSK-3 is a downstream target of Akt and an important
component of Wnt signaling. Akt inhibited GSK-3 activation
by inducing its phosphorylation (15, 45). We showed that
GSK-3 expression inhibited PI3K- and Akt-induced dorsal
phenotype and neural marker expression. In contrast, the ex-
pression of DN-GSK-3 induced dorsal phenotype and neural
marker expression. These results are consistent with previous
reports showing that overexpression of GSK-3 suppresses dor-
sal differentiation, whereas inhibition of GSK-3 is necessary
and sufficient to initiate dorsal axis specification (46). Mam-
malian GSk-3 can rescue the sgg/zw3 mutant phenotype con-
nected with wg signal transduction and Notch signaling (47).
Genetic evidence suggests that sgg/zw3 behaves as a constitu-
tively active kinase and is inhibited by wg signaling (48).
Therefore, our results provide the direct link between PI3K/Akt
signaling mediated by growth factors and the GSK-3/-cate-
FIG. 5. Effects of PI3K, Akt, and GSK-3 on the expression of neural and ventral markers. A, embryos at the two-cell stage were injected
into the animal pole with mRNAs encoding -gal, p110*, p85iSH2, Myr-Akt, DN-Akt, GSK-3, or DN-GSK-3 respectively. Animal caps were
dissected at stages 8.5–9 and cultured in 67% Leibovitz’s L-15 medium until the equivalent of stage 13. Total RNA was isolated from the animal
caps and assayed for the expression of NCAM, Otx2, HoxB9, Xvent1, Xvent2, BMP-4, Xmsx1, and EF-1 by RT-PCR. EF-1 mRNA expression was
used as an internal control. Total RNAs from a whole embryo at the equivalent stage were used as a positive control (second lane from the right),
and the reaction without the addition of reverse transcriptase (No RT) was used as a negative control (far right lane). B, embryos at the two-cell
stage were injected into the animal pole with mRNAs encoding -gal, p110*, p110* plus p85iSH2, p110* plus DN-Akt, p110* plus GSK-3,
p85iSH2 plus Myr-Akt, p85iSH2 plus GSK-3-DN, Myr-Akt, Myr-Akt plus DN-Akt, Myr-Akt plus GSK-3, and DN-GSK-3 plus DN-Akt,
respectively. Animal caps were dissected at stages 8.5–9 and cultured in 67% Leibovitz’s L-15 medium until the equivalent of stage 13. Total RNA
was isolated from the animal caps and analyzed for mRNA levels of NCAM, Otx2, HoxB9, Xvent1, Xvent2, BMP-4, Xmsx1, and EF-1. Total RNAs
from a whole embryo at the equivalent stage were used as a positive control (second lane from the right). Negative control reactions (far right lane)
were performed with total RNAs obtained from the embryos in the absence of reverse transcriptase (No RT) to confirm the absence of
contaminating genomic DNA. C, schematic presentation of PI3K/Akt signaling in axis induction and neurogenesis.
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nin pathway regulated by Wnt signaling and will help to elu-
cidate the molecular mechanism of neurogenesis and dorsal
axis formation.
In dorsoventral patterning, BMP-4 blocks the dorsalizing
action of the DN-GSK-3 and appears to function downstream
of GSK-3 in dorsoventral axis specification (46). Based on a
number of previous studies, PI3K may activate two separate
signal transduction pathways, one in mesoderm induction in-
volving the activation of extracellular signal-regulated kinase
in response to the fibroblast growth factor (33) and the other in
neural development involving the inhibition of GSK-3 (43, 46).
In this study, we demonstrated that PI3K is involved in neu-
rogenesis during Xenopus embryonic development and that the
PI3K signal transmits through Akt and GSK-3. Taken to-
gether, our results reveal a novel role for PI3K signaling in
both mesoderm induction and neural development during Xe-
nopus embryogenesis. It remains to test the potential upstream
signals that depend on PI3K activity to elicit neural tissue
differentiation and to study the cross-talk between PI3K/Akt
signaling and other signaling pathways in neurogenesis.
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